Drug intelligence / Profile preview

2'-deoxycytidine

Development stage
Phase 2
Modality
Small Molecules
01

Overview

**2'-Deoxycytidine** is a naturally occurring pyrimidine deoxynucleoside composed of the nucleobase cytosine attached to a deoxyribose sugar. It is one of the four standard nucleosides in DNA and serves as a building block for DNA synthesis. In biological systems, it can be phosphorylated to form deoxycytidine triphosphate (dCTP), which is incorporated into DNA by various DNA polymerases or reverse transcriptases[8][10]. It also acts as a substrate for enzymes such as deoxycytidine kinase and deaminase. Pharmacologically, it has been investigated for its potential anticancer properties due to its ability to inhibit certain kinases (e.g., IL‑2 receptor kinase and Toll-like receptor kinase), inhibit DNA polymerase activity, and interfere with thermal expansion during replication[8]. However, it is not an approved pharmaceutical drug but has been studied in clinical trials primarily as an investigational agent[1].

Other names
1-(2-deoxy-β-D-ribofuranosyl)cytosine2(1H)-Pyrimidinone, 4-amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-4-amino-1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-2(1h)-pyrimidinoneDeoxyribose cytidineDoxecitineCytidine, 2'-deoxy-
02

Targets

DNA polymerase familyIL-2R (Interleukin-2/interleukin-15 receptor complex)TLR (Toll-like receptors)

Beyond the preview

Go deeper on 2'-deoxycytidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2'-deoxycytidine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call